BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Non-alcoholic fatty liver disease
1
Liver stiffness measurements in patients with metabolic dysfunction-associated steatotic liver disease: Updates on the method effectiveness and perspectives
7/25/2025 12:09:44 PM | Browse: 17 | Download: 29
2
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics
6/26/2025 7:27:54 AM | Browse: 32 | Download: 197
3
Are mesenchymal stem/stromal cells a novel avenue for the treatment of non-alcoholic fatty liver disease?
5/26/2025 9:15:10 AM | Browse: 39 | Download: 215
4
Nonalcoholic fatty liver disease following laparoscopic duodenum-preserving pancreatic total head resection vs laparoscopic pancreaticoduodenectomy: A retrospective cohort study
4/2/2025 10:54:11 AM | Browse: 79 | Download: 371
5
Induced pluripotent stem cells-derived mesenchymal stem cells for modelling and treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Challenges and opportunities
2/24/2025 5:39:17 AM | Browse: 66 | Download: 336
6
ILF3 inhibits p-AMPK expression to drive non-alcoholic fatty liver disease progression
2/20/2025 8:40:00 AM | Browse: 90 | Download: 401
7
Liver function linked to bone health: A bibliometric of the liver-bone axis
2/20/2025 8:39:56 AM | Browse: 82 | Download: 320
8
Clinical profiles and their interaction of concurrent metabolic associated steatotic liver disease and hepatitis B virus infection
11/29/2024 2:50:17 PM | Browse: 124 | Download: 457
9
Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease
11/26/2024 7:20:28 AM | Browse: 87 | Download: 338
10
Vitamin D 1,25-Dihydroxyvitamin D₃ reduces lipid accumulation in hepatocytes by inhibiting M1 macrophage polarization
11/12/2024 12:23:35 PM | Browse: 115 | Download: 519
11
Addressing the alarming link between nonalcoholic fatty liver disease and cardiovascular mortality in men
9/19/2024 12:00:22 PM | Browse: 146 | Download: 398
12
Impact of non-alcoholic fatty liver disease on coronavirus disease 2019: A systematic review
8/21/2024 11:22:32 PM | Browse: 121 | Download: 490
13
Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction–associated steatotic liver disease
8/9/2024 12:51:13 PM | Browse: 144 | Download: 446
14
Excess cardiovascular mortality in men with non-alcoholic fatty liver disease: A cause for concern!
7/24/2024 1:09:01 PM | Browse: 143 | Download: 444
15
Quantitative assessment of self-management in patients with non-alcoholic fatty liver disease: An unmet clinical need
7/1/2024 7:39:37 AM | Browse: 129 | Download: 366
16
From non-alcoholic fatty liver disease to metabolic-associated steatotic liver disease: Rationale and implications for the new terminology
6/20/2024 3:42:22 AM | Browse: 218 | Download: 371
17
In-hospital outcomes in COVID-19 patients with non-alcoholic fatty liver disease by severity of obesity: Insights from national inpatient sample 2020
6/20/2024 3:42:22 AM | Browse: 157 | Download: 580
18
Non-alcoholic fatty liver disease in type 2 diabetes: Emerging evidence of benefit of peroxisome proliferator-activated receptors agonists and incretin-based therapies
6/14/2024 9:10:00 AM | Browse: 139 | Download: 408
19
Management of non-alcoholic fatty liver disease: Lifestyle changes
6/6/2024 5:43:14 AM | Browse: 211 | Download: 598
20
Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver disease
5/22/2024 11:33:24 AM | Browse: 138 | Download: 467
21
Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease
5/22/2024 11:33:24 AM | Browse: 141 | Download: 523
22
Metabolic dysfunction-associated fatty liver disease and low muscle strength: A comment
5/5/2024 10:12:21 AM | Browse: 155 | Download: 467
23
Genetically predicted fatty liver disease and risk of psychiatric disorders: A mendelian randomization study
5/5/2024 10:11:21 AM | Browse: 178 | Download: 571
24
Prevalence and outcome of sarcopenia in non-alcoholic fatty liver disease
4/19/2024 3:18:01 AM | Browse: 164 | Download: 569
25
Non-alcoholic fatty liver disease and sleep disorders
3/27/2024 1:28:19 PM | Browse: 188 | Download: 662
26
Sex and racial disparities in non-alcoholic fatty liver disease-related cardiovascular events: National inpatient sample analysis (2019)
3/21/2024 9:42:02 AM | Browse: 227 | Download: 661
27
Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect
2/26/2024 1:28:46 PM | Browse: 227 | Download: 798
28
Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges
1/26/2024 7:56:29 AM | Browse: 280 | Download: 785
29
From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
12/25/2023 6:03:15 AM | Browse: 239 | Download: 673
30
Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
9/25/2023 9:07:43 AM | Browse: 299 | Download: 920
31
Emerging therapeutic options for non-alcoholic fatty liver disease: A systematic review
8/22/2023 7:39:26 AM | Browse: 304 | Download: 934
32
Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease
7/25/2023 11:07:10 AM | Browse: 297 | Download: 815
33
Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients
6/25/2023 2:17:08 PM | Browse: 312 | Download: 984
34
Novel multi-parametric diagnosis of non-alcoholic fatty liver disease using ultrasonography, body mass index, and Fib-4 index
6/16/2023 9:52:18 AM | Browse: 303 | Download: 1184
35
Prospective study comparing hepatic steatosis assessment by magnetic resonance imaging and four ultrasound methods in 105 successive patients
6/7/2023 6:39:13 AM | Browse: 349 | Download: 1366
36
Hypothyroidism and non-alcoholic fatty liver disease: A coincidence or a causal relationship?
5/24/2023 9:31:05 AM | Browse: 312 | Download: 844
37
Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications
5/7/2023 7:47:34 AM | Browse: 320 | Download: 863
38
Peptic ulcer disease in non-alcoholic fatty liver disease hospitalizations: A new challenge on the horizon in the United States
4/20/2023 7:26:29 AM | Browse: 312 | Download: 965
39
Acoustic radiation force impulse predicts long-term outcomes in a large-scale cohort: High liver cancer, low comorbidity in hepatitis B virus
4/13/2023 8:14:59 AM | Browse: 327 | Download: 1284
40
Research progress on the mitochondrial mechanism of age-related non-alcoholic fatty liver
4/7/2023 5:51:03 AM | Browse: 299 | Download: 938
41
To scan or not to scan: Use of transient elastography in an integrated health system
3/22/2023 11:20:34 AM | Browse: 371 | Download: 1178
42
Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study
2/24/2023 1:35:50 PM | Browse: 372 | Download: 1092
43
Progressive changes in platelet counts and Fib-4 scores precede the diagnosis of advanced fibrosis in NASH patients
2/24/2023 1:35:50 PM | Browse: 363 | Download: 1088
44
Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate
2/24/2023 1:35:50 PM | Browse: 372 | Download: 889
45
Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease
1/20/2023 1:48:21 PM | Browse: 365 | Download: 804
46
Influence of non-alcoholic fatty liver disease on non-variceal upper gastrointestinal bleeding: A nationwide analysis
1/16/2023 6:02:17 AM | Browse: 353 | Download: 1098
47
Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
1/6/2023 2:52:58 AM | Browse: 368 | Download: 767
48
Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease
12/27/2022 10:06:45 AM | Browse: 395 | Download: 898
49
Prognostic performance of an index based on lactic dehydrogenase and transaminases for patients with liver steatosis and COVID-19
9/29/2022 10:42:42 AM | Browse: 582 | Download: 2183
50
Non-alcoholic fatty liver disease: Is surgery the best current option and can novel endoscopy play a role in the future?
9/23/2022 12:48:56 AM | Browse: 498 | Download: 973
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345